Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13770474 | 0.77 | ALDH1A1 (0.33) | THRBALDH1A1 | |
| SCHEMBL11552985 | 0.70 | CTDSP1 (0.50) | THRBALDH1A1 | |
| SCHEMBL9118629 | 0.68 | CTDSP1 (0.37) | THRBALDH1A1 | |
| SCHEMBL19164699 | 0.68 | CTDSP1 (0.44) | THRBALDH1A1 | |
| SCHEMBL15829649 | 0.67 | GNAI3 (0.32) | — | |
| SCHEMBL21184287 | 0.67 | — | — | |
| SCHEMBL20412236 | 0.67 | — | — | |
| SCHEMBL11338454 | 0.67 | THRB (0.53) | THRB | |
| Hydrochloric Acid SCHEMBL9635896 | 0.67 | CTDSP1 (0.51) | THRB | |
| Hydrochloric Acid SCHEMBL3759338 | 0.67 | CTDSP1 (0.36) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466216-B2 | Low odor binders curable at room temperature | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-06-18 | — | — | US | disclosed |
| US-8453849-B2 | Anti-microbial matrix and filtration system | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-06-04 | — | — | US | disclosed |
| US-8123959-B2 | Treatment of solid particles with functional agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-02-28 | — | — | US | disclosed |
| US-20110006009-A1 | ANTI-MICROBIAL MATRIX AND FILTRATION SYSTEM | 3M INNOVATIVE PROPERTIES COMPANY | 2011-01-13 | — | — | US | disclosed |
| US-7566381-B2 | Low odor binders curable at room temperature | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-07-28 | — | — | US | disclosed |
| US-20090134099-A1 | TREATMENT OF SOLID PARTICLES WITH FUNCTIONAL AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2009-05-28 | — | — | US | disclosed |
| US-20080093310-A1 | ANTI-MICROBIAL MEDIA AND METHODS FOR MAKING AND UTILIZING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2008-04-24 | — | — | US | disclosed |
| US-20070187056-A1 | Low odor binders curable at room temperature | KIMBERLY-CLARK WORLDWIDE, INC. | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090134099-A1 | TREATMENT OF SOLID PARTICLES WITH FUNCTIONAL AGENTS | CAPG, FBL, MYD88 | THRB 4569/4885ALDH1A1 4672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.